Please assess the completion status of the following clinical trial:

Trial Title: The Efficacy and Safety of Qizhiweitong Granule on Patients With Functional Dyspepsia in a Multi-center Clinical Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. patient with written ICF signed~2. patient with functional dyspepsia diagnosed by the Rome III criteria~3. age between 18y and 65y;male or female.~4. patient without gastric ulcers, erosive gastritis or other gastric organic diseases according to the endoscopy in the past one year in the hospital~5. patient without hepatobiliary and pancreatic diseases according to B-ultrasoundin the past one year in the hospital~6. patient with normal ECG (QT interval in the normal range) within one month prior to enrollment in this center~7. patient with symptoms of only one subtype of functional dyspepsia~Exclusion Criteria:~1. history of abdominal surgery;~2. take drugs related to gastrointestinal motility or gastric acid secretion and gastric acid drugs, anti-Helicobacter pylori drugs within 5 days of inclusion~3. suffering from hepatobiliary and pancreatic diseases with B ultrasound~4. suffering from high blood pressure and uncontroled hypertension~5. diabetes mellitus~6. have history of thyroid disease, systemic sclerosis, systemic lupus erythematosus~7. severe mental disorders~8. pregnant women, breastfeeding women or those who plan to become pregnant~9. allergy to Qizhiweitong particle~10. have symptoms of both subtypes of functional dyspepsia

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Qizhiweitong granule (Type: EXPERIMENTAL): 2.5g/time,tid,oral administration,6 weeks
- Placebo (Type: PLACEBO_COMPARATOR): 2.5g/time,tid,oral administration,6 weeks

Based on this trial design, predict the completion outcome and termination type (if applicable).